Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT07739459 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions

DRUG: Zanubrutinib

Sponsor

The Lymphoma Academic Research Organisation

Collaborators

[object Object]
[object Object]